Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (71-80 of 255) with videos related to

Pageof 26
Sort By:
Infection|July 1, 1988
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized studyF Petersen, M Thornquist, C Buckner, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Martin C Tom, Daniel P Cahill, Jan C Buckner, et al.
Cancer|August 15, 1996
Brain metastases from colorectal carcinoma. The long term survivorsG F Farnell, J C Buckner, T L Cascino, et al.
Journal of the Neurological Sciences|September 3, 2019
Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastomaLucie Petrova, Panagiotis Korfiatis, Ondra Petr, et al.
Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.
Journal of Digital Imaging|August 9, 2017
Residual Deep Convolutional Neural Network Predicts MGMT Methylation StatusPanagiotis Korfiatis, Timothy L Kline, Daniel H Lachance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trialsMichelle R Mahoney, Daniel J Sargent, Michael J O'Connell, et al.
Cancer|May 20, 1998
Management of recurrent meningeal hemangiopericytomaE Galanis, J C Buckner, B W Scheithauer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomasRavi D Rao, Stephan D Thomé, Judith O'Fallon, et al.
Journal of Clinical Pharmacology|May 16, 2015
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposureAlexander K Berg, Jan C Buckner, Evanthia Galanis, et al.
Pageof 26

Showing results (71-80 of 255) with videos related to

Sort By:
Pageof 26
Infection|July 1, 1988
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized studyF Petersen, M Thornquist, C Buckner, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Martin C Tom, Daniel P Cahill, Jan C Buckner, et al.
Cancer|August 15, 1996
Brain metastases from colorectal carcinoma. The long term survivorsG F Farnell, J C Buckner, T L Cascino, et al.
Journal of the Neurological Sciences|September 3, 2019
Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastomaLucie Petrova, Panagiotis Korfiatis, Ondra Petr, et al.
Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.
Journal of Digital Imaging|August 9, 2017
Residual Deep Convolutional Neural Network Predicts MGMT Methylation StatusPanagiotis Korfiatis, Timothy L Kline, Daniel H Lachance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trialsMichelle R Mahoney, Daniel J Sargent, Michael J O'Connell, et al.
Cancer|May 20, 1998
Management of recurrent meningeal hemangiopericytomaE Galanis, J C Buckner, B W Scheithauer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomasRavi D Rao, Stephan D Thomé, Judith O'Fallon, et al.
Journal of Clinical Pharmacology|May 16, 2015
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposureAlexander K Berg, Jan C Buckner, Evanthia Galanis, et al.
Pageof 26